首页 | 本学科首页   官方微博 | 高级检索  
     


Pseudotumoral recto-sigmoid herpes simplex virus type 2 in an HIV-infected patient: Dramatic improvement with thalidomide
Affiliation:1. Service de Médecine Interne, Institut Mutualiste Montsouris, Paris, France;2. Service d’Urologie, Clinique Turin, Paris, France;3. Service de Gastro-entérologie, Institut Mutualiste Montsouris, Paris, France;1. Human Biology Department, Stanford University, Stanford, CA 94305, USA;1. School of Chemistry and Environment, South China Normal University, Guangzhou 510006, China;2. Guangzhou Research and Creativity Biotechnology Co. Ltd, Guangzhou 510663, China;9. Hokkaido Institute of Public Health, Japan;10. Akita Prefectural Research Center for Public Health and Environment, Japan;11. Iwate Prefectural Research Institute for Environmental Sciences and Public Health, Japan;12. Yamagata Prefectural Institute of Public Health, Japan;13. Sendai City Institute of Public Health, Japan;14. Niigata Prefectural Institute of Public Health and Environmental Sciences, Japan;15. Niigata City Institute of Public Health and Environment, Japan;p. Ibaraki Prefectural Institute of Public Health, Japan;q. Tochigi Prefectural Institute of Public Health and Environmental Science, Japan;r. Utsunomiya City Institute of Public Health and Environment Science, Japan;s. Gunma Prefectural Institute of Public Health and Environmental Sciences, Japan;t. Chiba Prefectural Chuo Meat Sanitary Inspection Station, Japan;u. Saitama City Institute of Health Science and Research, Saitama Prefectural Institute of Public Health, Japan;v. Yokohama City Institute of Public Health, Japan;w. Kawasaki City Institute for Public Health, Japan;x. Sagamihara City Institute of Public Health, Japan;y. Yamanashi Institute of Public Health and Environment, Japan;z. Nagano Environmental Conservation Research Institute, Japan;11. Ishikawa Prefectural Institute of Public Health and Environmental Science, Japan;12. Gifu Municipal Institute of Public Health, Japan;13. Nagoya City Public Health Research Institute, Japan;14. Gifu Prefectural Research Institute for Health and Environmental Sciences, Japan;15. Kyoto City Institute of Health and Environmental Science, Japan;16. Osaka City Health Center, Japan;17. Sakai City Public Health Department, Japan;18. Hyogo Prefectural Institute of Public Health Science, Japan;19. Kobe Institute of Health, Japan;110. Amagasaki City Institute of Public Health, Japan;111. Nara Prefecture Institute of Health, Japan;112. Wakayama Prefectural Research Center of Environment and Public Health, Japan;113. Wakayama City Institute of Public Health, Japan;114. Tottori Prefectural Institute of Public Health and Environment, Japan;115. Shimane Prefectural Institute of Public Health and Environmental Science, Japan;1p. Okayama Prefectural Institute for Environmental Science and Public Health, Japan;1q. Hiroshima Prefectural Technology Research Institute, Japan;1r. Hiroshima City Institute of Public Health, Japan;1s. Kagawa Prefectural Research Institute for Environmental Science and Public Health, Japan;1t. Tokushima Prefectural Public Health Pharmaceutical and Environmental Sciences Center, Japan;1u. Ehime Prefectural Institute of Public Health and Environmental Science, Japan;1v. Kochi Prefectural Public Health and Environmental Science Research Institute, Japan;1w. Saga Prefectural Institute of Public Health and Pharmaceutical Research, Japan;1x. Okinawa Prefectural Institute of Health and Environment, Japan;1. Department of Bacteriology I, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan;2. Department of Microbiology, Tokyo Metropolitan Institute of Public Health, 3-24-1 Hyakunin-cho, Shinjuku-ku, Tokyo, 169-0073, Japan;3. Laboratory of Microbiology, Oita Prefectural Institute of Health and Environment, 2-8 Takae-Nishi, Oita, 870-1117, Japan;4. Department of Bacteriology, Toyama Institute of Health, 17-1 Naka-Taikouyama, Imizu, Toyama, 939-0363, Japan;5. Department of Microbiology, Fukushima Prefectural Institute of Public Health, 16-6 Mitouchi, Hokida, Fukushima, 960-8560, Japan;6. Division of Microbiology, Osaka Institute of Public Health, 1-3-69 Nakamichi, Higashinari-ku, Osaka, 537-0025, Japan;7. Department of Public Health Sciences, Yamaguchi Prefectural Institute of Public Health and Environment, 2-5-67 Aoi, Yamaguchi 753-0821, Japan;8. Division of Microbiology, Kanagawa Prefectural Institute of Public Health, 1-3-1 Shimomachiya, Chigasaki, Kanagawa, 253-0087, Japan;1. Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology, Ministry of Education, Department of Chemistry, Tsinghua University, Beijing 100084, China;2. College of Chemical Engineering, Hebei Key Laboratory for Environment Photocatalytic and Electrocatalytic Materials, North China University of Science and Technology, Tangshan 063009, China;3. State Key Lab of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China
Abstract:
Keywords:HSV-2  Pseudotumoral  Thalidomide  HIV
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号